Psychiatr. praxi 2018; 19(2): 64-66 | DOI: 10.36290/psy.2018.039

Huntington’s disease as a neuropsychiatric problem

doc. MUDr. Bc. Libor Ustohal, Ph.D.1,2, MUDr. Marie Obdržálková1, Mgr. et Mgr. Monika Víchová1
1 Psychiatrická klinika LF MU a FN Brno
2 Středoevropský technologický institut Masarykovy univerzity (CEITEC MU), Brno

The article summarizes basic data about diagnostics and treatment of Huntington’s disease. It emphasizes the neuropsychiatricbasis of the disease with not only motor symptoms but also with various psychiatric symptoms and cognitive deficit. These factsare confirmed with one case study.

Keywords: Huntington’s disease, motor symptoms, psychiatric symptoms, cognitive deficit, treatment

Received: April 2, 2019; Accepted: April 4, 2019; Prepublished online: April 4, 2019; Published: June 26, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ustohal L, Obdržálková M, Víchová M. Huntington’s disease as a neuropsychiatric problem. Psychiatr. praxi. 2018;19(2):64-66. doi: 10.36290/psy.2018.039.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Roth J. Huntingtonova nemoc. Cesk Slov Neurol N 2010; 73/106(2): 107-123.
    2. van Duijn, Craufurd D, Hubers AAM, Giltay EJ, Bonelli R, Rickards H, Anderson KE, van Walsem MR, van der Mast RC, Orth M, Landwehrmeyer GB, the European Huntington's Disease Network Behavioural Phenotype Working Group. Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY). J Neurol Neurosurg Psychiatry 2014; 85: 1411-1418. Go to original source... Go to PubMed...
    3. Eddy CM, Parkinson EG, Rickards HE. Changes in mental state and behaviour in Huntington's disease. Lancet Psychiatry 2016; 3(11): 1079-1086. Go to original source... Go to PubMed...
    4. Paoli RA, Botturi A, Ciammola A, Silani V, Prunas C, Lucchiari C, Zugno E, Caletti E. Neuropsychiatric Burden in Huntington's Disease. Brain Sci 2017; 7(67): 1-15. Go to original source... Go to PubMed...
    5. Saldanha Ramos AR, Garrett C. Huntington's Disease: Premotor Phase. Neurodegener Dis 2017; 17: 313-322. Go to original source... Go to PubMed...
    6. Saenz-Farret M, Zuniga-Ramirez C, Ramirez-Gomez CC, Montilla-Uzcategui V, Micheli F. Neuropsychiatric Symptoms and Premanifest Huntington's Disease. Mov Disord 2017; 32(3): 481. Go to original source... Go to PubMed...
    7. van Duijn E, Vrijmoeth EM, Giltay EJ, Landwehrmeyer B, REGISTRY investigators of the European Huntington's Disease Network. J Affect Disord 2017; 228: 194-204. Go to original source... Go to PubMed...
    8. Shannon KM, Fraint A. Therapeutic Advances in Huntington's Disease. Mov Disord 2015; 30(11): 1539-1546. Go to original source... Go to PubMed...
    9. Klempíř J, Roth J. Terapeutické možnosti poruch hybnosti u Huntingtonovy nemoci. Neurol praxi 2015; 16(4): 209-214.
    10. Moulton CD, Hopkins CW, Bevan-Jones WR. Systematic review of pharmacological treatments for depressive symptoms in Huntington's disease. Mov Disord 2014; 29(12): 1556-1561. Go to original source... Go to PubMed...
    11. Raja M, Soleti F, Bentivoglio AR. Lithium Treatment in Patients With Huntington's Disease and Suicidal Behavior. Mov Disord 2015; 30(10): 1438. Go to original source... Go to PubMed...
    12. Désaméricq G, Youssov K, Charles P, Saleh N, Olivier A, Sherer-Gagou C, Verny C, multidisciplinary working group, Bachoud-Lévi AC. Guidelines for clinical pharmacological practices in Huntington's disease. Rev Neurol (Paris) 2016; 172(8-9): 423-432. Go to original source... Go to PubMed...
    13. Hojgrová M, Víchová M, Ustohal L, Mayerová M. Kazuistika pacienta s Huntingtonovou chorobou. Psychiatr praxi 2017; 18(1): 38-41. Go to original source...

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.